On June 1, 2022 ChromaDex Corp. (NASDAQ:CDXC) reported that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Kevin Farr, will be presenting virtually at the 12th annual Invitational (Press release, ChromaDex, JUN 1, 2022, View Source [SID1234615345]). This three-day investor conference is expected to feature around 200+ companies.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The ChromaDex management team is scheduled to present on Wednesday, June 8th at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) at the Four Seasons Westlake Village.

ChromaDex management will also attend virtual one-on-one meetings with institutional investors throughout the day. For those interested in having a meeting with ChromaDex, please visit www.ldmicro.com for more information.

Webcast link: ChromaDex Investor Presentation – LD Micro Invitational

View ChromaDex’s profile here: View Source